Coloplast A/S Announces Leadership Change
In a significant shift for Coloplast A/S, CEO Kristian Villumsen has officially stepped down. Today marks the start of a new chapter as the Board of Directors mobilizes Lars Rasmussen to serve as interim CEO while the search for a permanent replacement is conducted.
Strategic Shift for the Future
This change comes at an opportune moment for Coloplast as it embarks on a fresh strategic period. The Board seeks a new leader to drive sustainable growth and enhance long-term value. Villumsen's departure opens the door for new visions and insights into the company's future strategies.
The Role of Lars Rasmussen
To guarantee a seamless transition, Lars Rasmussen, who has previously led the company as CEO from 2008 to 2018, has been appointed interim CEO. His extensive experience within the company is expected to guide Coloplast through this transitional period effectively.
Jette Nygaard-Andersen’s New Appointment
In addition to these changes, Jette Nygaard-Andersen will fill the role of interim Chair of the Board. She is set to work closely alongside Rasmussen, contributing her executive expertise and insights accumulated since she joined the Board in 2015.
Reflections on Leadership
During his tenure, Kristian Villumsen has played a pivotal role in strengthening Coloplast’s market presence. His leadership since 2018 has encompassed strategic acquisitions that positioned the company for enhanced competitiveness. As he transitions out, the Board expresses gratitude for his impactful contributions over the years.
Villumsen noted, "Over the past five years, we have made substantial acquisitions and expanded into new, high-growth segments, which strengthened Coloplast's base for future growth. I am proud of what we have accomplished together and wish the team all the best moving forward."
Looking Ahead: The Search for a New CEO
Coloplast now faces the task of identifying a new CEO who embodies the vision and competency to lead the company into its next phase. The Board aims to have someone in place within the next year, enabling a smooth and efficient continuity of leadership.
Executor Responsibilities During Transition
Throughout this interim period, Lars Rasmussen will maintain his regular responsibilities on the Board while stepping down from his role as Chair. This ensures that experienced leadership remains at the helm while the Board initiates the search for a new permanent CEO.
Upcoming Announcements
As Coloplast prepares for this leadership transition, it also has its H1 2024/25 Interim Report scheduled for release soon. It is to be unveiled on a set date alongside a conference call with both interim CEO Lars Rasmussen and CFO Anders Lonning-Skovgaard, where they will share insights into the company's direction and progress.
Contact Information for Further Inquiries
Coloplast's executive team remains open to inquiries during this transition. Investors and analysts can reach out to:
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111
Aleksandra Dimovska
Vice President, Investor Relations
Tel. +45 4911 2458
Simone Dyrby Helvind
Senior Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 2981
Frequently Asked Questions
Who is the new interim CEO of Coloplast?
Lars Rasmussen has been appointed as the interim CEO following Kristian Villumsen's departure.
What prompted the leadership change at Coloplast?
The Board of Directors decided it was time for a new leadership direction as the company enters a new strategy period.
How long will Lars Rasmussen serve as interim CEO?
Rasmussen will serve in this capacity while the search for a new CEO is conducted, expected to last around twelve months.
Who assumes the role of interim Chair of the Board?
Jette Nygaard-Andersen is appointed as the interim Chair during Lars Rasmussen’s tenure as CEO.
When will Coloplast release its next financial report?
Coloplast's H1 2024/25 Interim Report will be published on a specified day, with a conference call scheduled at that time.
